Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran

[1] Endler G(2003)Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis Clin Chim Acta 330 31-55

[2] Mannhalter C(1996)A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698-3703

[3] Poort SR(2003)Long warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 1425-1434

[4] Rosendaal FR(2003)Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-therm prevention of recurrent venous thromboembolism N Engl J Med 349 631-639

[5] Reitsma PH(2006)Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population Hum Biol 78 403-412

[6] Bertina RM(1999)High prevalence of factor V Leiden in healthy Jordanian Arabs Thromb Haemost 81 582-584

[7] Ridker PM(2000)The prevalence of factor V R506Q mutation Leiden among apparently healthy Lebanese Am J Hematol 65 45-49

[8] Golhaber SZ(2000)Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population Am J Hematol 65 119-122

[9] Danielson E(1995)World distribution of factor V Leiden Lancet 346 1133-1134

[10] Kearon C(2000)Thrombophilic Mutations in Iran Thromb Haemost 83 351-352

[1] Endler G(2003)Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis Clin Chim Acta 330 31-55

[2] Mannhalter C(1996)A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698-3703

[3] Poort SR(2003)Long warfarin therapy for the prevention of recurrent venous thromboembolism N Engl J Med 348 1425-1434

[4] Rosendaal FR(2003)Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-therm prevention of recurrent venous thromboembolism N Engl J Med 349 631-639

[5] Reitsma PH(2006)Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population Hum Biol 78 403-412

[6] Bertina RM(1999)High prevalence of factor V Leiden in healthy Jordanian Arabs Thromb Haemost 81 582-584

[7] Ridker PM(2000)The prevalence of factor V R506Q mutation Leiden among apparently healthy Lebanese Am J Hematol 65 45-49

[8] Golhaber SZ(2000)Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population Am J Hematol 65 119-122

[9] Danielson E(1995)World distribution of factor V Leiden Lancet 346 1133-1134

[10] Kearon C(2000)Thrombophilic Mutations in Iran Thromb Haemost 83 351-352